| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
WOOJUNG BIO, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,237.00 |
| 52 Week High | ₩4,125.00 |
| 52 Week Low | ₩1,100.00 |
| Beta | 0.68 |
| 11 Month Change | -11.77% |
| 3 Month Change | -33.49% |
| 1 Year Change | -57.20% |
| 33 Year Change | -83.19% |
| 5 Year Change | -82.91% |
| Change since IPO | -78.44% |
Recent News & Updates
Revenues Working Against WOOJUNG BIO, Inc.'s (KOSDAQ:215380) Share Price Following 26% Dive
Jun 14
Is WOOJUNG BIO (KOSDAQ:215380) Weighed On By Its Debt Load?
May 23Shareholder Returns
| A215380 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 1.4% | -1.8% | -1.0% |
| 1Y | -57.2% | 0.7% | 7.4% |
Return vs Industry: A215380 underperformed the KR Life Sciences industry which returned 0.7% over the past year.
Return vs Market: A215380 underperformed the KR Market which returned 7.4% over the past year.
Price Volatility
| A215380 volatility | |
|---|---|
| A215380 Average Weekly Movement | 5.0% |
| Life Sciences Industry Average Movement | 5.8% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.1% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A215380's share price has been volatile over the past 3 months.
Volatility Over Time: A215380's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | n/a | www.woojungbsc.co.kr |
WOOJUNG BIO, Inc. provides research and laboratory services in Korea. The company offers environmental infection control. It also provides construction solutions, such as preventing clean and infected; hospital negative pressure isolation ward; pharmaceutical company's aseptic production rooms; general and animal laboratory; high-risk pathogen research facility; and HEPA box air conditioning systems.
WOOJUNG BIO, Inc. Fundamentals Summary
| A215380 fundamental statistics | |
|---|---|
| Market cap | ₩17.37b |
| Earnings (TTM) | -₩2.82b |
| Revenue (TTM) | ₩40.67b |
0.4x
P/S Ratio-6.2x
P/E RatioIs A215380 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A215380 income statement (TTM) | |
|---|---|
| Revenue | ₩40.67b |
| Cost of Revenue | ₩33.27b |
| Gross Profit | ₩7.40b |
| Other Expenses | ₩10.22b |
| Earnings | -₩2.82b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -200.89 |
| Gross Margin | 18.19% |
| Net Profit Margin | -6.94% |
| Debt/Equity Ratio | 232.1% |
How did A215380 perform over the long term?
See historical performance and comparison